(2026). Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two‐Center Retrospective Study. Thoracic Cancer.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two‐Center Retrospective Study."
Thoracic Cancer 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two‐Center Retrospective Study."
Thoracic Cancer, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.